By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aclaris Therapeutics 

101 Lindenwood Drive
Suite 400
Malvern  Pennsylvania  19355  U.S.A.
Phone: 484-324-7933 Fax: 484-324-7949


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aclaris (ACRS) Announces Pricing Of Public Offering Of Common Stock 8/11/2017 9:50:46 AM
Aclaris (ACRS) Announces Appointment Of Andrew Schiff To Board Of Directors 8/9/2017 10:43:17 AM
Aclaris (ACRS) Reports Second Quarter 2017 Financial Results 8/8/2017 12:52:36 PM
Aclaris (ACRS) Scoops Up St. Louis Startup in Deal Worth Up to $100M 8/8/2017 7:06:38 AM
Aclaris (ACRS) Submits Marketing Authorization Application In Europe For A-101 40% Topical Solution As A Novel Treatment For Seborrheic Keratosis 8/3/2017 11:41:57 AM
Aclaris (ACRS) Submits Investigational New Drug Application For ATI-50002 To Treat Alopecia Areata 8/2/2017 10:20:32 AM
Aclaris (ACRS) To Announce Second Quarter 2017 Financial Results On August 8, 2017 8/1/2017 1:46:16 PM
UPDATE - Aclaris (ACRS) To Announce Second Quarter 2017 Financial Results On August 8, 2017 8/1/2017 1:29:02 PM
Aclaris (ACRS) Initiates Phase IIb Clinical Trials Of A-101 For Topical Treatment Of Common Warts 6/29/2017 8:21:21 AM
Aclaris (ACRS) Reports First Quarter 2017 Financial Results 5/10/2017 12:10:31 PM
123456
//-->